Edition:
India

FibroGen Inc (FGEN.OQ)

FGEN.OQ on NASDAQ Stock Exchange Global Select Market

47.21USD
1:30am IST
Change (% chg)

$1.07 (+2.32%)
Prev Close
$46.14
Open
$46.33
Day's High
$47.59
Day's Low
$45.00
Volume
497,022
Avg. Vol
252,261
52-wk High
$68.15
52-wk Low
$37.29

Select another date:

Tue, Dec 18 2018

Photo

China first to approve AstraZeneca, FibroGen anaemia drug

LONDON China has become the first country to approve a new anaemia drug from AstraZeneca and FibroGen, well before decisions by regulators in the United States or Europe.

China first to approve AstraZeneca, FibroGen anaemia drug

LONDON China has become the first country to approve a new anaemia drug from AstraZeneca and FibroGen, well before decisions by regulators in the United States or Europe.

China first to approve AstraZeneca, FibroGen anaemia drug

LONDON, Dec 18 China has become the first country to approve a new anaemia drug from AstraZeneca and FibroGen, well before decisions by regulators in the United States or Europe.

Select another date: